These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 19519554)
1. Impact of aging on the angiogenic potential of the myocardium: implications for angiogenic therapies with emphasis on sirtuin agonists. Wykrzykowska JJ; Bianchi C; Sellke FW Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):119-32. PubMed ID: 19519554 [TBL] [Abstract][Full Text] [Related]
6. Recent insights into human coronary collateral development. Fujita M; Tambara K Heart; 2004 Mar; 90(3):246-50. PubMed ID: 14966033 [TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic effect of high-dose resveratrol in a swine model of metabolic syndrome. Robich MP; Chu LM; Chaudray M; Nezafat R; Han Y; Clements RT; Laham RJ; Manning WJ; Coady MA; Sellke FW Surgery; 2010 Aug; 148(2):453-62. PubMed ID: 20570307 [TBL] [Abstract][Full Text] [Related]
8. Reconstitution of coronary vasculature in ischemic hearts by plant-derived angiogenic compounds. Chen H; Peng P; Cheng L; Lin X; Chung SS; Li M Int J Cardiol; 2012 Apr; 156(2):148-55. PubMed ID: 21130507 [TBL] [Abstract][Full Text] [Related]
9. Calpain inhibition improves collateral-dependent perfusion in a hypercholesterolemic swine model of chronic myocardial ischemia. Sabe AA; Potz BA; Elmadhun NY; Liu Y; Feng J; Abid MR; Abbott JD; Senger DR; Sellke FW J Thorac Cardiovasc Surg; 2016 Jan; 151(1):245-52. PubMed ID: 26478238 [TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in cardiovascular disease: current status and therapeutic potential. Sellke FW; Simons M Drugs; 1999 Sep; 58(3):391-6. PubMed ID: 10493268 [TBL] [Abstract][Full Text] [Related]
11. Rebuilding the coronary vasculature: hedgehog as a new candidate for pharmacologic revascularization. Lavine KJ; Ornitz DM Trends Cardiovasc Med; 2007 Apr; 17(3):77-83. PubMed ID: 17418368 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines. Losordo DW; Dimmeler S Circulation; 2004 Jun; 109(21):2487-91. PubMed ID: 15173038 [No Abstract] [Full Text] [Related]
15. The paradoxical pro- and antiangiogenic actions of resveratrol: therapeutic applications in cancer and diabetes. Kamaleddin MA Ann N Y Acad Sci; 2016 Dec; 1386(1):3-15. PubMed ID: 27880855 [TBL] [Abstract][Full Text] [Related]
16. [The mechanisms of angiogenesis. Medical and therapeutic applications]. Couffinhal T; Dufourcq P; Daret D; Duplaà C Rev Med Interne; 2001 Nov; 22(11):1064-82. PubMed ID: 11817119 [TBL] [Abstract][Full Text] [Related]
17. TP508 (Chrysalin) reverses endothelial dysfunction and increases perfusion and myocardial function in hearts with chronic ischemia. Fossum TW; Olszewska-Pazdrak B; Mertens MM; Makarski LA; Miller MW; Hein TW; Kuo L; Clubb F; Fuller GM; Carney DH J Cardiovasc Pharmacol Ther; 2008 Sep; 13(3):214-25. PubMed ID: 18757834 [TBL] [Abstract][Full Text] [Related]